← All organizations

Adlai Nortye Biopharma Co., Ltd.

For profitWebsite ↗

Also known as: Adlai Nortye | Adlai Nortye Biopharma Co., Ltd. | Adlai Nortye USA Inc | ADLAI NORTYE USA INC. | Adlai Nortye US Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 31, 2026

Timeline

2010s

Jun 1, 2014
Adlai Nortye Biopharma Co., Ltd.— Founded

Drugs by trial phase (8 distinct, 8 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT07252479Lead sponsorPhase 1Jan 31, 2026
NCT05358691CollaboratorPhase 1Jan 30, 2023
NCT05191667Lead sponsorPhase 1Jan 18, 2022
NCT05519059Lead sponsorPhase 1Oct 11, 2021
NCT04999384Lead sponsorPhase 1Sep 27, 2021
NCT04999384Study directorPhase 1Sep 27, 2021
NCT04975958Study directorPhase 1Sep 7, 2021
NCT04975958Lead sponsorPhase 1Sep 7, 2021
NCT04338399Study directorPhase 3Jul 31, 2020
NCT04338399Lead sponsorPhase 3Jul 31, 2020
NCT04432857Study directorPhase 1Jun 30, 2020
NCT04432857Lead sponsorPhase 1Jun 30, 2020

Details

Founded: Hangzhou, CN Jun 1, 2014
Last known activity: Jan 31, 2026